ID   7E4.1.1
AC   CVCL_U727
SY   anti-FcRH1,2,3,5-7E4
DR   Wikidata; Q54605107
RX   Patent=US7888478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6338.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q96LA6; Human FCRL1/CD307a.
CC   Monoclonal antibody target: UniProtKB; Q96LA5; Human FCRL2/CD307b.
CC   Monoclonal antibody target: UniProtKB; Q96P31; Human FCRL3/CD307c.
CC   Monoclonal antibody target: UniProtKB; Q96RD9; Human FCRL5/CD307e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 6
//
RX   Patent=US7888478;
RA   Chang W., de Sauvage F.J., Eaton D.L., Ebens A.J. Jr., Frantz G.D.,
RA   Hongo J.-A.S., Koeppen H., Polson A., Smith V.;
RT   "Compositions and methods for the treatment of tumor of hematopoietic
RT   origin.";
RL   Patent number US7888478, 15-Feb-2011.
//